337 related articles for article (PubMed ID: 27208687)
21. Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
De Cock E; Krueger WA; Sorensen S; Baker T; Hardewig J; Duttagupta S; Müller E; Piecyk A; Reisinger E; Resch A
Infection; 2009 Apr; 37(2):123-32. PubMed ID: 19277465
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE
Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739
[TBL] [Abstract][Full Text] [Related]
23. Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration.
Renzoni AJ; Peksa GD; DeMott JM
Am J Emerg Med; 2021 Jun; 44():68-71. PubMed ID: 33581603
[TBL] [Abstract][Full Text] [Related]
24. Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan.
Lin PC; Wang BC; Kim R; Magyar A; Lai CC; Yang YW; Huang YC
J Microbiol Immunol Infect; 2016 Feb; 49(1):46-51. PubMed ID: 26454421
[TBL] [Abstract][Full Text] [Related]
25. Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
Gonzalez RP; Rostas J; Simmons JD; Allen J; Frotan MA; Brevard SB
Am J Surg; 2013 Mar; 205(3):255-8; discussion 258. PubMed ID: 23375761
[TBL] [Abstract][Full Text] [Related]
26. The Daniel K. Inouye College of Pharmacy Scripts: The Effects of Vancomycin Use and De-escalation in Patients Hospitalized with Pneumonia.
You AS; Fukunaga BT; Hanlon AL; Lozano AJ; Goo RA
Hawaii J Med Public Health; 2018 Oct; 77(10):261-267. PubMed ID: 30324005
[TBL] [Abstract][Full Text] [Related]
27. Pharmacist-Driven Methicillin-Resistant
Marinucci V; Louzon PR; Carr AL; Hayes J; Lopez-Ruiz A; Sniffen J
Ann Pharmacother; 2023 May; 57(5):560-569. PubMed ID: 36039495
[TBL] [Abstract][Full Text] [Related]
28. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
[TBL] [Abstract][Full Text] [Related]
29. Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Patel DA; Shorr AF; Chastre J; Niederman M; Simor A; Stephens JM; Charbonneau C; Gao X; Nathwani D
Crit Care; 2014 Jul; 18(4):R157. PubMed ID: 25053453
[TBL] [Abstract][Full Text] [Related]
30. Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.
Fernández-Barat L; Ferrer M; Sierra JM; Soy D; Guerrero L; Vila J; Li Bassi G; Cortadellas N; Martínez-Olondris P; Rigol M; Esperatti M; Luque N; Saucedo LM; Agustí C; Torres A
Crit Care Med; 2012 Aug; 40(8):2385-9. PubMed ID: 22622402
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A
Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613
[TBL] [Abstract][Full Text] [Related]
32. Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial.
Collins CD; Schwemm AK
Value Health; 2015 Jul; 18(5):614-21. PubMed ID: 26297089
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant
Doan K; Smoke S
Eur J Hosp Pharm; 2024 Jun; 31(4):327-331. PubMed ID: 36754620
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.
Wan Y; Li Q; Chen Y; Haider S; Liu S; Gao X
J Med Econ; 2016; 19(1):53-62. PubMed ID: 26490296
[TBL] [Abstract][Full Text] [Related]
35. Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.
Paonessa JR; Shah RD; Pickens CI; Lizza BD; Donnelly HK; Malczynski M; Qi C; Wunderink RG
Chest; 2019 May; 155(5):999-1007. PubMed ID: 30776365
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes of linezolid vs vancomycin in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia: retrospective analysis.
Chan JD; Pham TN; Wong J; Hessel M; Cuschieri J; Neff M; Dellit TH
J Intensive Care Med; 2011; 26(6):385-91. PubMed ID: 21606058
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Segarra-Newnham M; Church TJ
Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
[TBL] [Abstract][Full Text] [Related]
39. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for treatment failure in patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia.
Aston JL; Dortch MJ; Dossett LA; Creech CB; May AK
Surg Infect (Larchmt); 2010 Feb; 11(1):21-8. PubMed ID: 19689198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]